Literature DB >> 11196246

Enuresis--background and treatment.

T Nevéus1, G Läckgren, T Tuvemo, J Hetta, K Hjälmås, A Stenberg.   

Abstract

Nocturnal urinary continence is dependent on 3 factors: 1) nocturnal urine production, 2) nocturnal bladder function and 3) sleep and arousal mechanisms. Any child will suffer from nocturnal enuresis if more urine is produced than can be contained in the bladder or if the detrusor is hyperactive, provided that he or she is not awakened by the imminent bladder contraction. Urine production is regulated by fluid intake and several interrelated renal, hormonal and neural factors, foremost of which are vasopressin, renin, angiotensin and the sympathetic nervous system. Detrusor function is governed by the autonomic nervous system which under ideal conditions is under central nervous control. Arousal from sleep is dependent on the reticular activating system, a diffuse neural network that translates sensory input into arousal stimuli via brain stem noradrenergic neurons. Disturbances in nocturnal urine production, bladder function and arousal mechanisms have all been firmly implicated as pathogenetic factors in nocturnal enuresis. The group of enuretic children are, however, pathogenetically heterogeneous, and two main types can be discerned: 1) Diuresis-dependent enuresis - these children void because of excessive nocturnal urine production and impaired arousal mechanisms. 2) Detrusor-dependent enuresis - these children void because of nocturnal detrusor hyperactivity and impaired arousal mechanisms. The main clinical difference between the two groups is that desmopressin is usually effective in the former but not in the latter. There are two first-line therapies in nocturnal enuresis: the enuresis alarm and desmopressin medication. Promising second-line treatments include anticholinergic drugs, urotherapy and treatment of occult constipation.

Entities:  

Mesh:

Year:  2000        PMID: 11196246

Source DB:  PubMed          Journal:  Scand J Urol Nephrol Suppl        ISSN: 0300-8886


  18 in total

1.  Clinical case rounds in child and adolescent psychiatry: enuresis and ADHD in older children and an adolescent treated with stimulant medication: a case series.

Authors:  Lloyda B Williamson; Michael Gower; Thaddeus Ulzen
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2011-02

2.  Enuresis: A maturational lag.

Authors:  Norman M Wolfish
Journal:  Paediatr Child Health       Date:  2002-10       Impact factor: 2.253

3.  Psychological correlates of enuresis: a case-control study on an Italian sample.

Authors:  Gabrielle Coppola; Alessandro Costantini; Marzia Gaita; Daniele Saraulli
Journal:  Pediatr Nephrol       Date:  2011-04-30       Impact factor: 3.714

4.  Homotoxicological remedies versus desmopressin versus placebo in the treatment of enuresis: a randomised, double-blind, controlled trial.

Authors:  Pietro Ferrara; Giuseppina Marrone; Valentina Emmanuele; Alessandro Nicoletti; Antonio Mastrangelo; Eloisa Tiberi; Antonio Ruggiero; Alfonso Fasano; Fabrizia Paolini Paoletti
Journal:  Pediatr Nephrol       Date:  2007-02-20       Impact factor: 3.714

5.  Enuresis as a premorbid developmental marker of schizophrenia.

Authors:  Thomas M Hyde; Amy Deep-Soboslay; Bianca Iglesias; Joseph H Callicott; James M Gold; Andreas Meyer-Lindenberg; Robyn A Honea; Llewellyn B Bigelow; Michael F Egan; Esther M Emsellem; Daniel R Weinberger
Journal:  Brain       Date:  2008-07-31       Impact factor: 13.501

6.  Diagnostic value of the pediatric lower urinary tract symptom score in children with overactive bladder.

Authors:  Cem Akbal; Ahmet Şahan; T Emre Şener; Bahadır Şahin; Ilker Tinay; Tufan Tarcan; Ferruh Şimşek
Journal:  World J Urol       Date:  2013-12-24       Impact factor: 4.226

7.  Pupillometric assessment of autonomic nervous system in children with functional enuresis.

Authors:  Rusen Dundaroz; Tumer Turkbay; Uzeyir Erdem; Ayhan Congologlu; Onur Sakallioglu; Emre Tascilar
Journal:  Int Urol Nephrol       Date:  2008-10-14       Impact factor: 2.370

8.  [A suggested treatment algorithm in nocturnal enuresis with emphasis on partial responders].

Authors:  A-D Marschall-Kehrel; G Mürtz; G Kramer; K-P Jünemann; H Madersbacher; K Hjalmas
Journal:  Urologe A       Date:  2004-07       Impact factor: 0.639

9.  Tolterodine and imipramine in refractory enuresis; a placebo-controlled crossover study.

Authors:  Tryggve Nevéus; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2007-11-15       Impact factor: 3.714

10.  Non-dipping phenomenon in children with monosymptomatic nocturnal enuresis.

Authors:  Aydin Kahraman; Hasan Dursun; Sami Hatipoglu; Bahar Kural; Mustafa Sahin; Korhan Birgul; Mehmet Bedir Akyol
Journal:  Pediatr Nephrol       Date:  2013-03-20       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.